Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Inventory (2021 - 2025)

Historic Inventory for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $41.4 million.

  • Kiniksa Pharmaceuticals International's Inventory rose 4433.75% to $41.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.4 million, marking a year-over-year increase of 4433.75%. This contributed to the annual value of $26.4 million for FY2024, which is 1528.82% down from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Inventory stood at $41.4 million for Q3 2025, which was up 4433.75% from $48.2 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Inventory registered a high of $48.2 million during Q2 2025, and its lowest value of $2.2 million during Q1 2021.
  • Moreover, its 5-year median value for Inventory was $23.4 million (2023), whereas its average is $22.1 million.
  • As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Inventory soared by 50406.58% in 2022, and later plummeted by 1909.6% in 2025.
  • Kiniksa Pharmaceuticals International's Inventory (Quarter) stood at $3.7 million in 2021, then surged by 487.73% to $21.6 million in 2022, then skyrocketed by 44.09% to $31.1 million in 2023, then dropped by 15.29% to $26.4 million in 2024, then surged by 57.02% to $41.4 million in 2025.
  • Its Inventory was $41.4 million in Q3 2025, compared to $48.2 million in Q2 2025 and $22.1 million in Q1 2025.